IP Library Granted Patent US 11,254,734
Granted Patent B2
US 11,254,734 · App. 16/348,941 · Granted Feb 22, 2022

Fab molecules with a rodent hinge region and a non-rodent CH1 region

Inventors: Julia Neugebauer (Munich, DE); Steffen Runz (Munich, DE); Stefanie Urlinger (Munich, DE)
Assignee: MORPHOSYS AG
C07K16/18C07K2317/24C07K2317/522C07K2317/53C07K2317/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,254,734
App. No.
16/348,941
Granted
Feb 22, 2022
Kind
B2
Abstract

The disclosure relates to novel Fab molecules comprising a modified heavy chain constant region. The modified constant region prevents the recognition of the Fab molecules by anti-Fab antibodies present in a host's serum. The disclosure further relates to methods of generating such modified Fab molecules for biological, diagnostic, pharmaceutical and other uses.

Claims (14)

1. A Fab comprising a modified heavy chain constant region, wherein said modified heavy chain constant region comprises a CH1 domain and a hinge region, wherein the hinge region is of a rodent IgG isotype and consists of the amino acid sequence of any one of ERRNGGIGHKC (SEQ ID NO: 32), EERNGGIGHKC (SEQ ID NO: 93), ERRQGGIGHKC (SEQ ID NO: 34) or VPREC (SEQ ID NO: 26) and wherein the CH1 domain is a wildtype human IgG1 CH1 domain or any allotype of a wildtype human IgG1 CH1 domain.

2. The Fab of claim 1 , wherein the CH1 domain comprises at least the amino acid sequence of any one of DKKV (SEQ ID NO: 86), DKRV (SEQ ID NO: 87), EKKV (SEQ ID NO: 88), DKKI (SEQ ID NO: 89), DKGV (SEQ ID NO: 90) or DKEV (SEQ ID NO: 91) from position 212 to 215 according to EU numbering.

3. The Fab of claim 1 , wherein the Fab CH1 domain consists of the amino acid sequence of any one of

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKV (SEQ ID NO: 1),

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRV (SEQ ID NO: 2),

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKI (SEQ ID NO: 7),

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVEKKV (SEQ ID NO: 8),

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKGV (SEQ ID NO: 9) or

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKEV (SEQ ID NO: 10.

4. The Fab of claim 1 , wherein the CH1 domain comprises the amino acid substitution. D212E, K214G, K214E, R214G, R214G or V215I.

5. The Fab of claim 1 , comprising a modified heavy chain constant region comprising a CH1 domain and a hinge region in order from N- to C-terminus, and wherein the CH1 domain consists of an amino acid sequence of any one of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 7-10.

6. The Fab of claim 1 , comprising a modified heavy chain constant region consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 70-76.

7. The Fab of claim 1 , comprising a modified heavy chain constant region comprising a CH1 domain and a hinge region in order from N- to C-terminus, and wherein the CH1 domain consists of the amino acid sequence

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKEV (SEQ ID NO: 10) and the hinge region consists of the amino acid sequence ERRQGGIGHKC (SEQ ID NO: 34).

Assignments (2)
CHANGE OF NAME Recorded May 1, 2025
From: MORPHOSYS AG
To: MORPHOSYS GMBH
Reel/Frame 071149/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2019
From: NEUGEBAUER, JULIA; RUNZ, STEFFEN; URLINGER, STEFANIE
To: MORPHOSYS AG.
Reel/Frame 049139/0140 →
Priority Claims (1)
EP 16198591 · Nov 14, 2016 · regional
Continuity (1)
Related Publication 20190345236A1 · Nov 14, 2019